Wyniki wyszukiwania:

Innovative instruments to stem the tide of cardiometabolic diseases are needed, especially in primary care (PC). A measurement of the ratio: triglycerides (TG) to HDL-Cholesterol (HDL-C), known as atherogenic dyslipidemia index (TG/HDL-C) (a biomarker of plasma atherogenicity & insulin resistance), may be helpful in PC, since it can shed some light on early detection of asymptomatic patients with high cardiovascular (CV) risk. This work explores the correlations between TG/HDL-C, lipid and anthropometric parameters, coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM), in PC...